vs
Ategrity Specialty Insurance Co Holdings（ASIC）与Cytek Biosciences, Inc.（CTKB）财务数据对比。点击上方公司名可切换其他公司
Ategrity Specialty Insurance Co Holdings的季度营收约是Cytek Biosciences, Inc.的1.9倍（$116.1M vs $62.1M），Ategrity Specialty Insurance Co Holdings净利率更高（19.5% vs -70.9%，领先90.5%）
Ategrity Specialty Insurance Co Holdings是一家特种保险控股企业，提供商业财产及意外伤害保险解决方案，主营超额与盈余线保险业务，服务美国本土建筑、医疗、小型企业等细分领域，为标准保险公司通常不承接的特殊风险提供定制化保单。
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
ASIC vs CTKB — 直观对比
营收规模更大
ASIC
是对方的1.9倍
$62.1M
净利率更高
ASIC
高出90.5%
-70.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.1M | $62.1M |
| 净利润 | $22.7M | $-44.1M |
| 毛利率 | — | 52.9% |
| 营业利润率 | 25.6% | -9.0% |
| 净利率 | 19.5% | -70.9% |
| 营收同比 | — | 8.1% |
| 净利润同比 | — | -557.1% |
| 每股收益（稀释后） | $0.45 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASICCTKB
| Q4 25 | — | $62.1M | ||
| Q3 25 | $116.1M | $52.3M | ||
| Q2 25 | $101.8M | $45.6M | ||
| Q1 25 | — | $41.5M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | — | $51.5M | ||
| Q2 24 | — | $46.6M | ||
| Q1 24 | — | $44.9M |
净利润ASICCTKB
| Q4 25 | — | $-44.1M | ||
| Q3 25 | $22.7M | $-5.5M | ||
| Q2 25 | $17.6M | $-5.6M | ||
| Q1 25 | — | $-11.4M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $941.0K | ||
| Q2 24 | — | $-10.4M | ||
| Q1 24 | — | $-6.2M |
毛利率ASICCTKB
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% | ||
| Q1 24 | — | 51.3% |
营业利润率ASICCTKB
| Q4 25 | — | -9.0% | ||
| Q3 25 | 25.6% | -17.6% | ||
| Q2 25 | 21.9% | -23.3% | ||
| Q1 25 | — | -36.1% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | -8.2% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | — | -23.9% |
净利率ASICCTKB
| Q4 25 | — | -70.9% | ||
| Q3 25 | 19.5% | -10.5% | ||
| Q2 25 | 17.3% | -12.2% | ||
| Q1 25 | — | -27.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | -22.4% | ||
| Q1 24 | — | -13.8% |
每股收益（稀释后）ASICCTKB
| Q4 25 | — | — | ||
| Q3 25 | $0.45 | — | ||
| Q2 25 | $0.39 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.3M | $90.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $588.6M | $341.7M |
| 总资产 | $1.4B | $461.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASICCTKB
| Q4 25 | — | $90.9M | ||
| Q3 25 | $34.3M | $93.3M | ||
| Q2 25 | $23.5M | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M | ||
| Q1 24 | — | $168.8M |
股东权益ASICCTKB
| Q4 25 | — | $341.7M | ||
| Q3 25 | $588.6M | $378.6M | ||
| Q2 25 | $559.7M | $377.6M | ||
| Q1 25 | — | $379.6M | ||
| Q4 24 | — | $395.7M | ||
| Q3 24 | — | $385.5M | ||
| Q2 24 | — | $389.1M | ||
| Q1 24 | — | $392.6M |
总资产ASICCTKB
| Q4 25 | — | $461.5M | ||
| Q3 25 | $1.4B | $494.9M | ||
| Q2 25 | $1.4B | $493.3M | ||
| Q1 25 | — | $482.6M | ||
| Q4 24 | — | $499.5M | ||
| Q3 24 | — | $491.2M | ||
| Q2 24 | — | $483.7M | ||
| Q1 24 | — | $492.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $41.1M | $-771.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-1.8M |
| 自由现金流率自由现金流/营收 | — | -2.9% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | 1.81× | — |
| 过去12个月自由现金流最近4个季度 | — | $-8.8M |
8季度趋势，按日历期对齐
经营现金流ASICCTKB
| Q4 25 | — | $-771.0K | ||
| Q3 25 | $41.1M | $-3.9M | ||
| Q2 25 | $50.8M | $108.0K | ||
| Q1 25 | — | $-125.0K | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | — | $4.0M |
自由现金流ASICCTKB
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $5.2M | ||
| Q1 24 | — | $3.4M |
自由现金流率ASICCTKB
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 11.0% | ||
| Q1 24 | — | 7.6% |
资本支出强度ASICCTKB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | 1.3% |
现金转化率ASICCTKB
| Q4 25 | — | — | ||
| Q3 25 | 1.81× | — | ||
| Q2 25 | 2.88× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | — | 14.05× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIC
暂无分部数据
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
